Abstract Background and Hypothesis Schizophrenia spectrum disorders (SSDs) produce severe symptoms, disability, and premature mortality, but only partially effective symptomatic treatments exist. Treatment development is impeded by lack of insight into disease mechanisms or objective biomarkers for clinical trials. Adv...
Mohini Ranganathan, Susan G. Jakob, F. Cerrato et al.· Schizophrenia bulletin· 0 citations
Genetic studies of serious mental illness (SMI, including schizophrenia and bipolar disorder) have implicated two classes of risk variant: common variants1-3, each of small effect but collectively accounting for most population-level risk, and ultra-rare coding variants4,5 which confer large risk in a small number of i...
Greta Gerdes, V. Tozzo, S. Service et al.· medRxiv· 0 citations
A new data resource is introduced – the Penn Longitudinal Executive functioning in Adolescent Development study (Penn LEAD) – that combines longitudinal multimodal imaging data with rich clinical and cognitive phenotyping that will accelerate research on EF development in psychiatry.
B. Sevchik, G. Shafiei, Kristin Murtha et al.· Scientific Data· 0 citations
Results indicate that relatively preserved higher-order cognition in autistic females may help explain subtler clinical presentations observed in some females with ASD, and have implications for improving clinical detection of autistic females, addressing their specific needs, and understanding biological mechanisms un...
Oscar W. H. Wong, Sophia Zhu, Jonathan Wt Chow et al.· Research Square· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.